Agrenvec

阿格伦维克是一家商业化公司。面向研发市场的重组蛋白和抗体产于100%无动物非转基因植物系统。我们保证我们的客户*地为他们生产市场上好的重组蛋白和抗体，以及研究任何由我们的客户建议的任何蛋白质的研发项目。

阿格伦维克是一家商业化公司。面向研发市场的重组蛋白和抗体产于100%无动物非转基因植物系统。我们保证我们的客户*地为他们生产市场上重组蛋白和抗体，以及研究任何由我们的客户建议的任何蛋白质的研发项目。

Agrenvec is a European biotech specialized in plant production of mammalian recombinant proteins and antibodies for the R&D market. Was created as a start-up company in 2002 with the in-licensing of several patents from the INIA (Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria).

We are focused on  the development, manufacture and marketing, of products and services for the R&D and Industrial markets. Our Company owns a patented technology platform allowing us a high-throughput production of Animal free fully active recombinant proteins with complex 3D structure and with a purity of 97%.